Michael P Brown

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Metastatic Colorectal Cancer

Top Venues

Journal for immunotherapy of cancer

Cancer reports (Hoboken, N.J.)

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Tessa Gargett, Nga T H Truong, Bryan Gardam, Wenbo Yu, Lisa M Ebert, Amy Johnson, Erica C F Yeo, Nicole L Wittwer, Gonzalo Tapia Rico, Jesikah Logan, Purany Sivaloganathan, Maria Collis, Andrew Ruszkiewicz, Michael P Brown
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers. Journal for immunotherapy of cancer 12 (5) (2024)
Tessa Gargett, Nga T H Truong, Bryan Gardam, Wenbo Yu, Lisa M Ebert, Amy Johnson, Erica C F Yeo, Nicole L Wittwer, Gonzalo Tapia Rico, Jesikah Logan, Purany Sivaloganathan, Maria Collis, Andrew Ruszkiewicz, Michael P Brown
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers. Journal for immunotherapy of cancer 12 (5) (2024)
Tessa Gargett, Nga T H Truong, Bryan Gardam, Wenbo Yu, Lisa M Ebert, Amy Johnson, Erica C F Yeo, Nicole L Wittwer, Gonzalo Tapia Rico, Jesikah Logan, Purany Sivaloganathan, Maria Collis, Andrew Ruszkiewicz, Michael P Brown
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers. Journal for immunotherapy of cancer 12 (5) (2024)
Jake Robert Thompson, Julia Lai-Kwon, Rachael Lisa Morton, Alexander D Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P Brown, Alexander M Menzies, Grant A McArthur, Serigne N Lô, Georgina V Long, Iris Bartula
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy 15 (8) (2023)
Charlotte Lemech, Keith Dredge, Darryn Bampton, Edward Hammond, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski, Andrew Haydon, Nick Pavlakis, Matthew Burge, Michael P Brown, David Goldstein
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors. Journal for immunotherapy of cancer 11 (1) (2023)
Jake Robert Thompson, Julia Lai-Kwon, Rachael Lisa Morton, Alexander D Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P Brown, Alexander M Menzies, Grant A McArthur, Serigne N Lô, Georgina V Long, Iris Bartula
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy 15 (8) (2023)
Charlotte Lemech, Keith Dredge, Darryn Bampton, Edward Hammond, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski, Andrew Haydon, Nick Pavlakis, Matthew Burge, Michael P Brown, David Goldstein
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors. Journal for immunotherapy of cancer 11 (1) (2023)
Aaron R Hansen, John J Park, Jermaine Coward, Ben Markman, Charlotte Lemech, James C Kuo, Amy Prawira, Michael P Brown, Sarwan Bishnoi, Dusan Kotasek, R Matthew Strother, Rasha Cosman, Rila Su, Yiding Ma, Zenglian Yue, Hui-Han Hu, Rachel Wu, Peiqi Li, Archie N Tse
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer. British journal of cancer (2023)
Jake Robert Thompson, Julia Lai-Kwon, Rachael Lisa Morton, Alexander D Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P Brown, Alexander M Menzies, Grant A McArthur, Serigne N Lô, Georgina V Long, Iris Bartula
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy 15 (8) (2023)
Jake Robert Thompson, Julia Lai-Kwon, Rachael Lisa Morton, Alexander D Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P Brown, Alexander M Menzies, Grant A McArthur, Serigne N Lô, Georgina V Long, Iris Bartula
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy (2023)
Charlotte Lemech, Keith Dredge, Darryn Bampton, Edward Hammond, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski, Andrew Haydon, Nick Pavlakis, Matthew Burge, Michael P Brown, David Goldstein
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors. Journal for immunotherapy of cancer 11 (1) (2023)
Nicole L Wittwer, Alexander H Staudacher, Vasilios Liapis, Pina Cardarelli, Harriet Warren, Michael P Brown
An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer. Journal for immunotherapy of cancer 11 (3) (2023)
Nicole L Wittwer, Alexander H Staudacher, Vasilios Liapis, Pina Cardarelli, Harriet Warren, Michael P Brown
An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer. Journal for immunotherapy of cancer 11 (3) (2023)
Charlotte Lemech, Keith Dredge, Darryn Bampton, Edward Hammond, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski, Andrew Haydon, Nick Pavlakis, Matthew Burge, Michael P Brown, David Goldstein
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors. Journal for immunotherapy of cancer 11 (1) (2023)
Tessa Gargett, Lisa M Ebert, Nga T H Truong, Paris M Kollis, Kristyna Sedivakova, Wenbo Yu, Erica C F Yeo, Nicole L Wittwer, Briony L Gliddon, Melinda N Tea, Rebecca Ormsby, Santosh Poonnoose, Jake Nowicki, Orazio Vittorio, David S Ziegler, Stuart M Pitson, Michael P Brown
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for immunotherapy of cancer 10 (9) (2022)
Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, James M G Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen J Gogas, Stéphane Dalle, Nicolas Meyer, Paolo Antonio Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C Hassel, Caroline Robert, Matteo S Carlino, Anna Maria Di Giacomo, Marcus O Butler, Eva Muñoz Couselo, Michael P Brown, Piotr Lukasz Rutkowski, Andrew M Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis de la Cruz Merino, Andre van der Westhuizen, Alexander M Menzies, Sandra Re, Tuba Bas, Veerle de Pril, Julia Braverman, Daniel J Tenney, Hao Tang, Georgina V Long
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Nadia El Khawanky, Amy Hughes, Wenbo Yu, Renier Myburgh, Tony Matschulla, Sanaz Taromi, Konrad Aumann, Jade Clarson, Janaki Manoja Vinnakota, Khalid Shoumariyeh, Christoph Cornelius Miething, Angel F Lopez, Michael P Brown, Justus Duyster, Lutz Hein, Markus Gabriel Manz, Timothy P Hughes, Deborah L White, Agnes S M Yong, Robert Zeiser
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nature communications 12 (1) (2021)
Vasilios Liapis, William Hsieh, Nicole L Wittwer, Tessa Gargett, Andreas Evdokiou, Prab Takhar, Stacey E Rudd, Paul S Donnelly, Michael P Brown, Alexander H Staudacher
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models. Molecular imaging and biology 23 (6) (2021)
C Glenn Begley, Mark Ashton, Jonathan B Baell, Michael Bettess, Michael P Brown, Brett Carter, William N Charman, Christopher Davis, Simon Fisher, Ian Hector Frazer, Anand Gautam, Michael P Jennings, Philip Kearney, Eloise Keeffe, Darren Kelly, Angel F Lopez, Michael A McGuckin, Michael W Parker, Craig Rayner, Brett Roberts, James S Rush, Mark Sullivan
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers. Science translational medicine 13 (612) (2021)
Alexander H Staudacher, Yanrui Li, Vasilios Liapis, Michael P Brown
The RNA-binding protein La/SSB associates with radiation-induced DNA double-strand breaks in lung cancer cell lines. Cancer reports (Hoboken, N.J.) (2021)
Paul Ambrose Reid, Alexander H Staudacher, Loredana G Marcu, Ian Olver, Leyla Moghaddasi, Michael P Brown, Eva Bezak
Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose. Head & neck 43 (10) (2021)
Erica C F Yeo, Michael P Brown, Tessa Gargett, Lisa M Ebert
The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy. Cells 10 (3) (2021)
Anna Mislang, Richard Mollard, Gonzalo Tapia Rico, W Douglas Fairlie, Erinna F Lee, Tiffany J Harris, Roger Aston, Michael P Brown
A preliminary assessment of oral monepantel's tolerability and pharmacokinetics in individuals with treatment-refractory solid tumors. Cancer chemotherapy and pharmacology 86 (5) (2020)